These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27509321)

  • 1. Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation.
    Feys HB; Pottel H; Coene J; Vandewalle G; Vandekerckhove P; Compernolle V
    Vox Sang; 2016 Nov; 111(4):431-433. PubMed ID: 27509321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent aggregates in apheresis platelet concentrates.
    Feys HB; Coene J; Devloo R; Van Aelst B; Pottel H; Vandekerckhove P; Compernolle V
    Vox Sang; 2015 May; 108(4):368-77. PubMed ID: 25754290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates.
    Feys HB; Van Aelst B; Devloo R; Vandekerckhove P; Compernolle V
    Vox Sang; 2016 May; 110(4):344-51. PubMed ID: 26646710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress.
    Maurer-Spurej E; Larsen R; Labrie A; Heaton A; Chipperfield K
    Transfus Apher Sci; 2016 Aug; 55(1):35-43. PubMed ID: 27470708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet concentrates, from whole blood or collected by apheresis?
    van der Meer PF
    Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T; Alt-Mayer T; Greinacher A; Bux J
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?
    Schrezenmeier H; Seifried E
    Vox Sang; 2010 Jul; 99(1):1-15. PubMed ID: 20059760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The content of the LRS chamber provides a new quality tool for the characterization of the donor platelet profile.
    Vasconcelos E; Sousa AP; Seghatchian J; Maurício R; Figueiredo AC; Leitão C; Sousa G
    Transfus Apher Sci; 2005 Apr; 32(2):221-5. PubMed ID: 15784457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM; Murphy MF; Harrison P
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impedance aggregometric analysis of platelet function of apheresis platelet concentrates as a function of storage time.
    Glas M; Bauer JV; Eichler H; Volk T
    Scand J Clin Lab Invest; 2016 Dec; 76(8):664-670. PubMed ID: 27701904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China.
    Chen J; Zhou G; Fu X; Li S; Li Y; Kang J; Chen H; Zhou L; Fu Y
    BMC Public Health; 2021 Apr; 21(1):819. PubMed ID: 33926409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Storage of apheresis platelet concentrates after manual replacement of >95% of plasma with PAS 5.
    Morrison A; McMillan L; Radwanski K; Blatchford O; Min K; Petrik J
    Vox Sang; 2014 Oct; 107(3):247-53. PubMed ID: 24801569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous collection of platelets and cryoprecipitate by plasma-exchange donation.
    McLeod BC; Sassetti RJ; Owens EA; Scott JP
    Transfusion; 1989 May; 29(4):332-6. PubMed ID: 2497567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?].
    Lozano ML; Rivera J; Vicente V
    Med Clin (Barc); 2012 May; 138(12):528-33. PubMed ID: 21807386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling predonation testing strategies in platelet donations - Approach from low throughput apheresis blood center from India.
    Murugesan M; Padmanaban M; Malodan R; Chellaiya GK; Nayanar SK
    Asian J Transfus Sci; 2020; 14(2):131-136. PubMed ID: 33767539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tobacco smoking on platelet function in apheresis products in vitro.
    Scheinichen D; Heuft HG; Renken C; Jüttner B; Jaeger K; Schürholz T; Blasczyk R; Piepenbrock S; Elsner HA
    Vox Sang; 2004 May; 86(4):252-6. PubMed ID: 15144530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
    Hirani R; Peberdy J; Mondy P
    Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.